ADHD is a neurodevelopmental condition that affects both children and adults. It is characterised by symptoms such as ...

Prescriptions for methylphenidate, a central nervous system stimulant primarily used to treat attention deficit hyperactivity ...

Granules Pharmaceuticals, a wholly-owned subsidiary of Granules India, has received tentative approval from the US Food and ...

A stimulant drug used to treat ADHD has become the fastest-growing script on the Pharmaceutical Benefits Scheme, prompting ...

When the NHS recognised ADHD in adults in 2008, never in my wildest hypochondriacal dreams did I imagine it applied to me. I ...

Letters: Dr Vicky Cleak is frustrated with the lengthy registration process to practice, while Mona Sood and another reader are wary of NHS drug-based interventions ...

Granules India received tentative USFDA approval for Amphetamine Extended-Release Orally Disintegrating Tablets, offering 180 ...

The tentative approval by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application ...

Granules India arm gets USFDA tentative nod for generic ADHD tablets with 180-day exclusivity eligibility, expanding its ...

Granules India receives USFDA tentative approval for generic amphetamine extended-release tablets for ADHD treatment.

Granules said on December 22, 2025 it had received a tentative approval for the Amphetamine Extended-Release Orally Disintergrating Tablets in the 3.1mg, 6.3mg, 9.4mg, 12.5mg, 15.7mg and 18.8mg ...

Granules India rose 1.07% to Rs 619 after its arm Granules Pharmaceuticals, Inc has received tentative approval from the USFDA for its Abbreviated New Drug Application for generic Amphetamine Extended ...